Treatment And Prevention Of Heparin-Induced Thrombocytopenia

Publication Date: February 1, 2012
Last Updated: March 14, 2022

Recommendations

Screening for HIT

For patients receiving heparin in whom clinicians consider the risk of HIT to be >1%, we suggest that platelet count monitoring be performed every 2 or 3 days from day 4 to day 14 (or until heparin is stopped, whichever occurs first). (2, C)
307795
For patients receiving heparin in whom clinicians consider the risk of HIT to be <1%, we suggest that platelet counts not be monitored. (2, C)
307795

Overview

Title

Treatment And Prevention Of Heparin-Induced Thrombocytopenia

Authoring Organization

American College of Chest Physicians